NPCENeuroPace, Inc.

$482M

Q1 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$23M+24.3% YoY

Gross Profit

$17M77.0% margin

Operating Income

-$5M-22.9% margin

Net Income

-$7M-29.3% margin

EPS (Diluted)

$-0.21

QoQ Revenue Growth

+4.9%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$8M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$110M

Total Liabilities

$86M

Stockholders' Equity

$24M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23M	$18M	+24.3%
Gross Profit	$17M	$13M	+30.0%
Operating Income	-$5M	-$8M	+31.8%
Net Income	-$7M	-$9M	+26.2%

Geographic Segments

Non-US

$100,000100%

NPCE Q1 2025 Earnings — NeuroPace, Inc. Revenue & Financial Results | Market Cap Arena